Myoclonus, ataxia, and hypoventilation: Response to L-5-hydroxytryptophan

H. Feit, J. Kirkpatrick, M. H. Van Woert, G. Pandian

Research output: Contribution to journalArticle

24 Scopus citations


Both hypoventilation and myoclonus were suppressed for 4 years with L-5-hydroxytryptophan and carbidopa in a patient with a syndrome of progressive myoclonus, ataxia, central neurogenic hypoventilation, mental retardation, motor neuropathy, and morphologic mitochondrial abnormalities in skeletal muscle.

Original languageEnglish (US)
Pages (from-to)109-112
Number of pages4
Issue number1
StatePublished - Jan 1983

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint Dive into the research topics of 'Myoclonus, ataxia, and hypoventilation: Response to L-5-hydroxytryptophan'. Together they form a unique fingerprint.

  • Cite this

    Feit, H., Kirkpatrick, J., Van Woert, M. H., & Pandian, G. (1983). Myoclonus, ataxia, and hypoventilation: Response to L-5-hydroxytryptophan. Neurology, 33(1), 109-112.